Aptus Pharma Limited (APPL)

BSE: ₹225.15
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Sep 2025 Mar 2026
Revenue from Operations 14.38 32.20
YOY Revenue Growth % - -
Other Income 0.01 0.12
Total Income 14.39 32.32
Total Expenses + 12.04 28.29
Cost of Materials Consumed 0.00 0.00
Employee Benefit Expense 2.30 2.90
Other Expenses 3.30 9.25
Operating Profit 2.34 3.90
OPM % 16.3% 12.1%
Profit Before Tax + 2.35 4.02
Tax Expense 2.35 4.02
Tax % 100% 100%
Profit After Tax 0.00 0.00
EPS (Basic) 3.46 4.19

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026
Revenue from Operations 46.57
YOY Revenue Growth % -
Other Income 0.13
Total Income 46.71
Total Expenses + 40.33
Employee Benefit Expense 5.21
Other Expenses 12.55
Operating Profit 6.24
OPM % 13.4%
Profit Before Exceptional 0.00
Exceptional Items 0.00
Profit Before Tax + 6.37
Tax Expense 6.37
Tax % 100%
Profit After Tax 0.00
EPS (Basic) 7.78

Balance Sheet

Particulars Mar 2026
ASSETS
Non-Current Assets + 8.30
Property, Plant & Equipment 2.71
Capital Work in Progress 0.00
Non-Current Investments 0.00
Goodwill 0.00
Other Intangible Assets 0.00
Current Assets + 35.24
Inventories 13.57
Trade Receivables 0.00
Cash and Cash Equivalents 1.03
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 0.00
Equity Share Capital 0.00
Other Equity 0.00
Non-Current Liabilities 0.88
Current Liabilities 19.31
Total Liabilities 0.00

Cash Flow Statement

Particulars Mar 2026
Cash from Operating Activities -6.86
Cash from Investing Activities -6.37
Cash from Financing Activities 9.04
Net Increase/Decrease in Cash -4.19